Revenue Recognition - Additional Information (Detail) - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Apr. 04, 2026 |
Mar. 29, 2025 |
|
| Deferred Revenue Arrangement [Line Items] | ||
| Payment receivable for specialty development project | 120 months | |
| Interest income on specialty development project | $ 2.6 | $ 2.9 |
| Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Automotive Industry [Member] | ||
| Deferred Revenue Arrangement [Line Items] | ||
| Concentration Risk Percentage1 | 31.00% | 31.00% |
| X | ||||||||||
- Definition Interest Income On Specialty Development Project. No definition available.
|
| X | ||||||||||
- Definition Payment receivable for specialty development project. No definition available.
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|